FTSE All-Share
5.326,71
PKT
+11,13
PKT
+0,21
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.07.21 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 19.07.21 | GSK Neutral | UBS AG | |
| 19.07.21 | GSK Underweight | Barclays Capital | |
| 16.07.21 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 16.07.21 | Diageo Market-Perform | Bernstein Research | |
| 16.07.21 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 16.07.21 | Rio Tinto Sell | UBS AG | |
| 16.07.21 | Rio Tinto Neutral | Goldman Sachs Group Inc. | |
| 16.07.21 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 16.07.21 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 15.07.21 | HSBC Neutral | Credit Suisse Group | |
| 15.07.21 | AstraZeneca Buy | UBS AG | |
| 14.07.21 | HSBC Sector Perform | RBC Capital Markets | |
| 14.07.21 | AstraZeneca Buy | UBS AG | |
| 13.07.21 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 13.07.21 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 12.07.21 | Vodafone Group Buy | UBS AG | |
| 12.07.21 | GSK Buy | Jefferies & Company Inc. | |
| 12.07.21 | Diageo Overweight | Barclays Capital | |
| 12.07.21 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 09.07.21 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 09.07.21 | Vodafone Group Buy | Kepler Cheuvreux | |
| 09.07.21 | Vodafone Group Overweight | Morgan Stanley | |
| 09.07.21 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 09.07.21 | Rio Tinto Neutral | Goldman Sachs Group Inc. | |
| 08.07.21 | Unilever Underweight | Morgan Stanley | |
| 08.07.21 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 08.07.21 | Rio Tinto Outperform | Credit Suisse Group | |
| 08.07.21 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 07.07.21 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 07.07.21 | HSBC Neutral | UBS AG | |
| 07.07.21 | Barclays Buy | UBS AG | |
| 07.07.21 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 07.07.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 07.07.21 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 07.07.21 | HSBC Buy | Goldman Sachs Group Inc. | |
| 06.07.21 | Barclays Buy | Goldman Sachs Group Inc. | |
| 07.07.21 | GSK Neutral | UBS AG | |
| 07.07.21 | GSK Equal-weight | Morgan Stanley | |
| 06.07.21 | BP Overweight | JP Morgan Chase & Co. |